News for Healthier Living

AACR: New CAR T Cell Therapy Benefits Patients with Advanced Thyroid Cancers

* Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors * One patient experienced a complete response, and one patient had a partial response * This type of cancer has limited treatment options, and most patients have a poor prognosis of six months or less * AIC100 is a CAR T cell therapy that targets the ICAM-1 protein on tumor cells

April 29, 2025


May 9 2025

May 8 2025

May 7 2025

May 6 2025

May 5 2025

May 2 2025

May 1 2025

April 30 2025

April 29 2025

April 28 2025

April 27 2025

April 26 2025

April 25 2025